References
1. Feodor Nilsson S, Andersen PK, Strandberg‐Larsen K, Nybo Andersen AM. Risk factors for miscarriage from a prevention perspective: a nationwide follow‐up study. BJOG: An International Journal of Obstetrics & Gynaecology. 2014;121(11):1375-1385.
2. Lamont K, Scott NW, Jones GT, Bhattacharya S. Risk of recurrent stillbirth: systematic review and meta-analysis. bmj.2015;350:h3080.
3. Melve KK, Skjaerven R, Rasmussen S, Irgens LM. Recurrence of stillbirth in sibships: population-based cohort study. American journal of epidemiology. 2010;172(10):1123-1130.
4. Black M, Shetty A, Bhattacharya S. Obstetric outcomes subsequent to intrauterine death in the first pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 2008;115(2):269-274.
5. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Reviews in obstetrics and gynecology. 2009;2(2):76.
6. Fritz R, Kohan-Ghadr H-R, Bolnick JM, et al. Noninvasive detection of trophoblast protein signatures linked to early pregnancy loss using trophoblast retrieval and isolation from the cervix (TRIC).Fertility and sterility. 2015;104(2):339-346. e334.
7. Medicine PCotASfR. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and sterility.2012;98(5):1103-1111.
8. Silver RM, Branch DW, Goldenberg R, Iams JD, Klebanoff MA. Nomenclature for pregnancy outcomes: time for a change. Obstetrics & Gynecology. 2011;118(6):1402-1408.
9. Bardos J, Hercz D, Friedenthal J, Missmer SA, Williams Z. A national survey on public perceptions of miscarriage. Obstetrics and gynecology. 2015;125(6):1313.
10. Kasak L, Rull K, Sõber S, Laan M. Copy number variation profile in the placental and parental genomes of recurrent pregnancy loss families.Scientific reports. 2017;7:45327.
11. Li T, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage.BJOG: An International Journal of Obstetrics & Gynaecology.2000;107(12):1471-1479.
12. THARAPEL AT, THARAPEL SA, BANNERMAN RM. Recurrent pregnancy losses and parental chromosome abnormalities: a review. BJOG: An International Journal of Obstetrics & Gynaecology. 1985;92(9):899-914.
13. Kavalier F. Investigation of recurrent miscarriages. In. Vol 331: British Medical Journal Publishing Group; 2005:121-122.
14. Franssen MT, Korevaar JC, Leschot NJ, et al. Selective chromosome analysis in couples with two or more miscarriages: case-control study.bmj. 2005;331(7509):137-141.
15. Warburton D, Kline J, Stein Z, Hutzler M, Chin A, Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. American journal of human genetics.1987;41(3):465.
16. Carey AZ, Blue NR, Varner MW, et al. A systematic review to guide future efforts in the determination of genetic causes of pregnancy loss.Frontiers in Reproductive Health. 2021:97.
17. Christiansen OB, Elson J, Kolte AM, et al. ESHRE guideline: recurrent pregnancy loss. Human Reproduction Open.2018;2018(2):hoy004-hoy004.
18. Franke KR, Crowgey EL. Accelerating next generation sequencing data analysis: an evaluation of optimized best practices for Genome Analysis Toolkit algorithms. Genomics & informatics. 2020;18(1).
19. Pedersen BS, Brown JM, Dashnow H, et al. Effective variant filtering and expected candidate variant yield in studies of rare human disease.NPJ Genomic Medicine. 2021;6(1):1-8.
20. Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature.2021;590(7845):290-299.
21. Karczewski K, Francioli L, Tiao G, Cummings B, Alföldi J, Wang Q. Genome Aggregation Database, C.(2020). The mutational constraint spectrum quantified from variation in. 141:434-443.
22. Kline J, Vardarajan B, Abhyankar A, et al. Embryonic lethal genetic variants and chromosomally normal pregnancy loss. Fertility and sterility. 2021;116(5):1351-1358.
23. Stanley KE, Giordano J, Thorsten V, et al. Causal Genetic Variants in Stillbirth. New England Journal of Medicine. 2020.
24. Shehab O, Tester DJ, Ackerman NC, Cowchock FS, Ackerman MJ. Whole genome sequencing identifies etiology of recurrent male intrauterine fetal death. Prenatal Diagnosis. 2017;37(10):1040-1045.
25. Teijeiro V, Yang D, Majumdar S, et al. DICER1 is essential for self-renewal of human embryonic stem cells. Stem cell reports.2018;11(3):616-625.
26. Page DJ, Miossec MJ, Williams SG, et al. Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of fallot. Circulation research. 2019;124(4):553-563.
27. Cubillos-Rojas M, Schneider T, Hadjebi O, et al. The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. Oncotarget. 2016;7(35):56083.
28. Aggarwal S, Bhowmik AD, Ramprasad VL, Murugan S, Dalal A. A splice site mutation in HERC1 leads to syndromic intellectual disability with macrocephaly and facial dysmorphism: further delineation of the phenotypic spectrum. American Journal of Medical Genetics Part A.2016;170(7):1868-1873.
29. van Woerden GM, Bos M, de Konink C, et al. TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development. Human mutation. 2021;42(4):445-459.
30. Samocha KE, Robinson EB, Sanders SJ, et al. A framework for the interpretation of de novo mutation in human disease. Nature genetics. 2014;46(9):944-950.
31. Quintero-Ronderos P, Laissue P. Genetic variants contributing to early recurrent pregnancy loss etiology identified by sequencing approaches. Reproductive Sciences. 2019:1933719119831769.
32. Cochery-Nouvellon E, Chauleur C, Demattei C, et al. The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples. Thrombosis and haemostasis. 2009;102(10):656-667.
33. Alonso A, Soto I, Urgellés MF, Corte JR, Rodríguez MJ, Pinto CR. Acquired and inherited thrombophilia in women with unexplained fetal losses. American journal of obstetrics and gynecology.2002;187(5):1337-1342.
34. Gray KJ, Wilkins-Haug L. Special issue on “Feto-Maternal Genomic Medicine”: a decade of incredible advances. In: Springer; 2020.
35. Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin–2 (FBN2) mutations result in the Marfan–like disorder, congenital contractural arachnodactyly. Nature genetics. 1995;11(4):456-458.
36. Quondamatteo F, Reinhardt DP, Charbonneau NL, Pophal G, Sakai LY, Herken R. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix biology. 2002;21(8):637-646.
37. Colley E, Hamilton S, Smith P, Morgan NV, Coomarasamy A, Allen S. Potential genetic causes of miscarriage in euploid pregnancies: a systematic review. Human reproduction update. 2019;25(4):452-472.
38. Rajcan-Separovic E. Next generation sequencing in recurrent pregnancy loss-approaches and outcomes. European Journal of Medical Genetics. 2020;63(2):103644.
39. Rahbari R, Wuster A, Lindsay SJ, et al. Timing, rates and spectra of human germline mutation. Nature genetics. 2016;48(2):126.
40. Campbell IM, Stewart JR, James RA, et al. Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics. The American Journal of Human Genetics. 2014;95(4):345-359.
41. Acuna-Hidalgo R, Veltman JA, Hoischen A. New insights into the generation and role of de novo mutations in health and disease.Genome biology. 2016;17(1):241.
42. Stessman HA, Bernier R, Eichler EE. A genotype-first approach to defining the subtypes of a complex disease. Cell.2014;156(5):872-877.
Table S1 . Biospecimen obtained from parent-offspring samples for WGS